However, no further details or survival data regarding KCNJ3 expression were given or discussed, as this study aimed to develop an ion channel gene signature (termed IC30) as prognostic tool in breast cancer, and KCNJ3 is not comprised in this final gene panel [33]. Here, KCNJ3 is linked to breast carcinoma.